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HIV-positive kidney transplants for HIV-positive 
individuals: Attitudes and concerns of South African 
patients and health care workers
Suzanne Gokool, June Fabian, W D Francois Venter, Catherine MacPhail, Saraladevi Naicker
To the Editor: In South Africa, an estimated 30% of the 
cadaveric donor pool is HIV-infected; in consequence, these 
organs are discarded. An undersupply of donor organs 
combined with limited resources tends to exclude HIV-positive 
patients from renal replacement programmes. We evaluated 
the acceptance of using HIV-positive donor kidneys for 
transplantation into HIV-infected recipients, and found that the 
vast majority (90% of health care workers and 80% of patients, 
N=20 and 80, respectively) found this approach acceptable for 
expanding the organ donor pool, which indicates broad patient 
and health care worker support for using HIV-infected donor 
kidneys.
Background
South Africa has one of the largest HIV epidemics and largest 
antiretroviral (ARV) access programmes in the world.1 With 
ARV therapy extending life expectancy, management of HIV-
infected individuals is increasingly focusing on age-, HIV- and 
ARV treatment-related co-morbidities.2 A serious co-morbidity 
is HIV-related end-stage kidney disease (ESKD), which has 
greatly increased the burden of chronic kidney disease (CKD) 
in South Africa – a morbidity for which the therapeutic 
infrastructure is already ill-equipped to cope with the renal 
complications caused by common conditions such as diabetes 
and hypertension.3 South Africa is, however, one of the few 
African countries to have private and state-funded dialysis and 
transplant programmes.
Comparative studies of treatment options for ESKD have 
shown that transplantation rather than dialysis is the most 
cost-effective form of treatment, greatly improving patients’ 
quality of life and survival.4,5 HIV-positive patients were 
previously excluded from renal replacement therapy owing 
to poor outcomes, but evidence indicates that transplantation 
in selected HIV-infected patients can be beneficial, as 1- and 
2-year survival rates were higher than of those maintained 
on dialysis.6 In addition, transplantation using both kidneys 
from the same donor for separate HIV-infected and -uninfected 
patients demonstrated that graft and patient survival were 
comparable in both recipient groups after 5 years.7
South African health policy guidelines have therefore 
been revised to allow HIV-infected patients access to dialysis 
and kidney transplantation, provided that they meet the 
eligibility criteria: a CD4 count >200 cells/µl; an undetectable 
HIV viral load; and adherence to a stable ARV regimen.8 
Unfortunately, most HIV-infected and uninfected patients are 
not offered access to chronic dialysis or transplantation owing 
to a shortage of dialysis slots and organ donors. A recent 
proposed solution is to use HIV-positive cadaveric donor 
kidneys for transplantation into HIV-infected recipients.9 The 
potential hazards surrounding this procedure are presently 
unquantifiable, but may include the transfer of resistant 
HIV strains or opportunistic infections, and transplantation 
of a kidney with undiagnosed HIV-CKD. The attitudes, 
concerns and acceptability of using HIV-positive kidneys for 
transplantation into HIV-positive recipients were assessed by 
interviewing HIV-infected and uninfected individuals, with 
and without renal disease, and health care workers.
Methods
Study participants fulfilling the transplant programme 
inclusion criteria, as well as those without kidney disease, 
were recruited from the appropriate clinics by convenience 
sampling (N=20 for each group) at Charlotte Maxeke 
Johannesburg, Helen Joseph and Chris Hani Baragwanath 
hospitals in Johannesburg. They were placed into 4 groups: 
group 1 – HIV-infected individuals on ARVs without identified 
kidney disease; group 2 – HIV-infected individuals on ARVs 
with established stages (1 - 5) of CKD, including those on 
dialysis; group 3 – HIV-uninfected individuals on dialysis; and 
group 4 – HIV-uninfected individuals with a functioning graft 
following transplant. Half of the total number of interviewees 
were HIV-positive, and 75% suffered from CKD. An additional 
group comprising health care workers in the field of kidney 
disease and HIV was interviewed using a scenario-based 
questionnaire. After invitation to participate and providing 
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signed, informed consent, questionnaire-based interviews were 
conducted in the participants’ chosen indigenous language 
with the aid of a translator. Univariate comparisons were tested 
using the χ2 test, and all p-values are reported as two-sided 
with a significance value at p<0.05 (STATA 10).
Results
Attitudes of patients
Table I shows the demographic and clinical characteristics of 
the study groups. All participants were asked whether they 
thought that people with HIV infection should receive kidney 
transplants, and whether they would accept an HIV-positive 
kidney. If the answer to the latter question was ‘No’, they 
were asked whether other individuals on ARVs should have 
access to kidney transplants. Most respondents in all groups 
thought access should be granted to HIV-positive people, with 
the highest proportion of affirmative responses (90% and 95%) 
coming from the two HIV-positive groups. The responses 
from these groups were not statistically different (p=0.077). 
HIV-positive patients were more likely to say that they would 
accept an HIV-positive kidney graft (p<0.001); while a minority 
of HIV-negative patients would accept one. All groups thought 
that HIV-positive individuals on stable ARVs should be offered 
HIV-positive kidneys; the highest positive responses came 
Table I. Demographic and clinical characteristics of study participants grouped according to HIV status and the presence of 
end-stage kidney disease
     Group 1  Group 2  Group 3  Group 4              Overall
     N=20  N=20  N=20  N=20               %
Demographic characteristics 
   Age group (years) (%)
   19 - 29    20  15  20  25              20.0
   30 - 39    60  35  30  15              35.0
   40 - 49    10  40  30  35              28.8
   50+     10  10  20  25              16.2
   Age (years) 
   Median     34.5  39.0  39.5  42.5              38.0
   IQR     30 - 39  34 - 46  31 - 47  30 - 50              31 - 45
   Gender (%)
   Male     25  55  60  55              48.8
   Ethnicity (%)
   Black     95  100  75  60              82.5
   White    5  0  15  20              10.0
   Coloured    0  0  0  15              3.8
   Indian    0  0  10  5              3.7
Clinical HIV-related information
   Length of time on ARVs 
   Median (months)   36  38  N/A  N/A              36
   IQR     30 - 46  27 - 48                  30 - 48
   Baseline CD4 count, 
   Median (cells/µl)    91.5  137  N/A  N/A              99
   IQR     33 - 150  63 - 259                  45 - 194
   Current CD4 count, 
   Median (cells/µl)   450  383  N/A  N/A              418
   IQR     368 - 595  310 - 479                  340 - 516
Clinical renal disease-related information
   Reason for kidney failure (%)
   CKD     N/A  10  20  15              15.0
   Diabetes    N/A  10  5  5              6.7
   Hypertension    N/A  50  60  55              55.0
   Other    N/A  30  15  25              23.3
IQR = inter-quartile range; ARVs = antiretrovirals; CKD = chronic kidney disease; N/A = question or information not applicable to particular group.
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from the HIV-uninfected groups 3 and 4 (75% and 83.3% 
respectively). HIV-infected participants were specifically asked 
whether they would accept kidneys from family members, 
whether HIV-infected or uninfected. The majority stated that 
they would accept kidneys from infected and uninfected family 
members.
Forty-five per cent of HIV-infected participants without 
kidney disease stated that they would choose transplantation 
as the preferred method of renal replacement therapy; 
25% would consider haemodialysis, peritoneal dialysis or 
transplantation. When asked if they would be willing to 
consider dialysis, 55% replied that they would, with an 
additional 20% noting that they would consider dialysis if they 
could afford it. Twenty-five per cent of participants said they 
would refuse dialysis as a treatment option, the most common 
(30%) reason for refusal among them being the time and high 
travel cost involved.
Attitudes of health care workers
Health care workers (N=20), who were predominantly nurses 
(55%), in renal units and ARV clinics were given clinical 
scenario-based questionnaires. Ninety per cent agreed 
that HIV-positive individuals should be provided with 
kidney transplants if patients met the proposed eligibility 
criteria. However, the need for education of the public to 
encourage organ donations (15%) and full information about 
transplantation (10%) was respectively noted by health care 
workers.
Discussion and conclusion
Our results suggest that both patients and health care workers 
find it acceptable to include HIV-positive cadaveric donors for 
transplantation into eligible HIV-positive recipients, despite 
the unknown risks. The key reasons given for providing 
transplants to HIV-positive individuals using HIV-positive 
kidneys were to afford them the opportunity for longer 
survival, to avoid discrimination because of their HIV 
status, and to allow them equal rights of health care access 
compared with HIV-negative patients. Our findings suggest 
that, unless clear biological risks in using HIV-positive grafts 
are identified, providing patients with full information about 
uncertainties and risks will allow them to make a decision on 
transplantation with HIV-positive kidneys. Such an approach 
would dramatically increase the donor pool of available 
kidneys. At the time of writing, 4 HIV-infected donor kidneys 
were successfully transplanted into HIV-positive recipients in 
South Africa.10 Research should now focus on graft survival 
and careful follow-up of recipients to assess short-, medium- 
and long-term risks associated with this new procedure.
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